ESMO Targeted Anticancer Therapies Congress 2021 ESMO Targeted Anticancer Therapies Congress 2021 Consulter le e-poster "AsiDNA™ targets drug-tolerant persister cells responsible of resistance to PARP inhibitors" (en anglais)